CAAS Capital Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-25,000
Closed -$1.09M 935
2021
Q1
$1.09M Hold
25,000
0.01% 391
2020
Q4
$1.16M Buy
+25,000
New +$1.16M 0.01% 275